Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2003
06/12/2003US20030109550 Substituted indazole compounds for the treatment of inflammation
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109526 Azo amino acids derivatives
06/12/2003US20030109518 Substituted 1,4-benzodiazepines and uses thereof
06/12/2003US20030109502 Novel compounds for modulating cell proliferation
06/12/2003US20030109497 Novel imidazolidine derivatives, their preparation and their use
06/12/2003US20030109493 Use of polysulphated cyclodextrins for treating osteoarthritis
06/12/2003US20030109491 Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109038 Chondrocyte precursors derived from human embryonic stem cells
06/12/2003US20030109000 Culture product; binding polypeptides containing activated end groups
06/12/2003US20030108928 MID 241 receptor, a novel G-protein coupled receptor
06/12/2003US20030108619 Synergistic mixture of casein polypeptide to promote calcium absorption and genistein which inhibits bone resorption and promotes osteogenesis; prevent decrease in bone density and onset of osteoporosis
06/12/2003US20030108593 Reduction inhibitory agent for active oxygen eliminating activity
06/12/2003US20030108558 Anticholesterol agents; rheumatic diseases; mutiple sclerosis; antidiabetic agents; administering protein extracted from animal liver
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108531 Genes for transfection into bony tissues
06/12/2003CA2537913A1 Prevention and treatment of androgen-deprivation induced osteoporosis
06/12/2003CA2469227A1 New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
06/12/2003CA2469078A1 Immunotherapeutic methods and systems
06/12/2003CA2468927A1 Ring fused pyrazole derivatives
06/12/2003CA2468558A1 "compressed annular tablet with molded triturate tablet for oral and intraoral"
06/12/2003CA2468525A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers of 4-[4-[(1r)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3s)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003CA2466751A1 Ep4 receptor agonist, compositions and methods thereof
06/11/2003EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
06/11/2003EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
06/11/2003EP1317486A1 Interferon-alpha induced gene
06/11/2003EP1317465A1 Purine derivatives
06/11/2003EP1317458A2 Interphenylene 7-oxabicyclic[2.2.1]heptane oxazoles as prostaglandin f2alpha antagonists
06/11/2003EP1317457A2 INTERHETEROARYL 7-OXABICYCLIC 2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F 2$g(a)? ANTAGONISTS
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317453A1 Isoxazoles and their use as inhibitors of erk
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317420A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317418A2 2-amino-2-alkyl-4 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317416A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1317267A2 Compositions containing diacyltartaric salts of (e)-metanicotine
06/11/2003EP1317263A1 Use of rhein for preparing a medicine for preventing articular cartilage damage
06/11/2003EP1317258A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
06/11/2003EP1131065B1 Dialkylfumarates for the treatment of autoimmune diseases
06/11/2003EP1060161B1 Matrix metalloproteinase inhibitors
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003CN1423748A Solution and crystal structures of MMP-13 active sidte and uses thereof
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423699A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
06/11/2003CN1423695A Antisense oligonucleotides
06/11/2003CN1423659A Recombinant gelatins
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1423528A Nutritional modules
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1422662A Medicine for treating bone and joint tuberculosis
06/11/2003CN1422647A Bone permeable blood-activating paste
06/11/2003CN1422646A Chinese medicinal preparation for treating osteoproliferation and various rheumatalgia
06/11/2003CN1422639A Dral medicine for treating rheumatism and atrophic diseases
06/11/2003CN1422637A Health-care product for improving sleep and increasing bone density
06/11/2003CN1422635A Bone-setting medicine
06/11/2003CN1422624A Medicine for treating bone fractuve and its preparation method and using method
06/11/2003CN1111066C Musk plaster for bone-set
06/11/2003CN1111053C Medicine for treating bone fracture and injury
06/11/2003CN1111043C Medicine for treating protrusion of lumber vertebral disc and its preparation
06/11/2003CN1111037C Bone and muscle bolus
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576668 Remedies for arthrosis deformans
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations,
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003CA2265708C Lipoxin compounds and their use in treating cell proliferative disorders
06/10/2003CA2200651C Sodium alendronate preparation for local administration
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/05/2003WO2003046580A1 Assay for screening candidate drugs for the treatment of inflammatory diseases
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 820